BetterScholar BetterScholar
9
Role
Title
Level Year L/R
🐜 Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
13 auth. Aamir Ahmed, G. Turner, B. King, L. Jones, David Culliford, D. McCance, J. Ardill, B. Johnston, G. Poston, M. Rees, ... M. Buxton-Thomas, Martyn Caplin, J. Ramage
8 2009
8
🐜
🐬 Carcinoid tumour of the appendix
A. Goede, Martyn Caplin, MC Winslet
7 2003
7
🐬
🐒 Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies
Raj Srirajaskanthan, Johnathan Watkins, Laura Marelli, K. Khan, Martyn Caplin
6 2009
6
🐒
🐒 Long‐term results of patients with malignant carcinoid syndrome receiving octreotide LAR
8 auth. C. Toumpanakis, Jacqueline Garland, Laura Marelli, Raj Srirajaskanthan, J. Soh, P. Davies, ... J. R. Buscombe, Martyn Caplin
5 2009
5
🐒
🐒 A review of thymic tumours.
Raj Srirajaskanthan, C. Toubanakis, M. Dusmet, Martyn Caplin
5 2008
5
🐒
🦁 Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma.
10 auth. Martyn Caplin, Kosser Khan, Kay Savage, Jurgen Rode, A. VarrΓ³, Dov Michaeli, ... Steve Grimes, Bernard Brett, R. Pounder, Amar Dhillon
5 1999
5
🦁
🐒 ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update
Dermot O'Toole, Reza Kianmanesh, Martyn Caplin
5 2016
5
🐒
🐒 Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.
8 auth. Raj Srirajaskanthan, C. Toumpanakis, A. Karpathakis, L. Marelli, Alexandra Quigley, M. Dusmet, ... T. Meyer, Martyn Caplin
5 2009
5
🐒
🐜 A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer.
11 auth. Tim Meyer, Martyn Caplin, Daniel H. Palmer, Juan W. Valle, Mike Larvin, J. Waters, ... F. Coxon, I. Borbath, Marc Peeters, E. Nagano, H. Kato
5 2010
5
🐜